COMPANY

jCyte

HQ: Newport Beach, CA source · jcyte.com ↗ · West Coast

Keywords: ophthalmology Retinitis Pigmentosa human retinal progenitor cells

Location: Newport Beach, CA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Timeline

Jun 20, 2025 Trial start Phase 2: Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP) source ↗
Dec 1, 2020 Trial start Phase 2: Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa source ↗
Mar 1, 2017 Trial start Phase 2: Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells in Adults With Retinitis Pigmentosa source ↗
2015-06 Trial start Phase 1/Phase 2: Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa source ↗

2026-12 (ESTIMATED) · Phase 2 · Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP) · NCT06912633

Estimated primary completion per ClinicalTrials.gov. Dates move.

Record	Title	Phase	Status	Start	Primary completion
NCT06912633	Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)	Phase 2	Active, not recruiting	Jun 20, 2025	2026-12 (estimated)
NCT04604899	Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa	Phase 2	Completed	Dec 1, 2020	Mar 22, 2022 (actual)
NCT03073733	Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells in Adults With Retinitis Pigmentosa	Phase 2	Completed	Mar 1, 2017	Nov 13, 2020 (actual)
NCT02320812	Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa	Phase 1/Phase 2	Completed	2015-06	Jul 19, 2017 (actual)